Trial Profile
Examination the efficacy of Mirabegron on patient with overactive bladder after treatment with a1 blocker for benign prostatic hyperplasia
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 01 Jun 2020
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 29 May 2020 Status changed from recruiting to active, no longer recruiting.
- 13 Nov 2015 New trial record